@article{article, title  = {{Efficacy and safety of abrocitinib in patients with severe and/or difficult-to-treat atopic dermatitis: a post hoc analysis of the randomized phase 3 JADE COMPARE trial}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/201122 http://dx.doi.org/10.1007/s40257-023-00785-5 }},

 year = {{2023}},

 month = {{5}},

 author = {{Simpson EL and Silverberg JI and Thyssen JP and Viguier M and Thaçi D and de Bruin-Weller M and Weidinger S and Chan G and DiBonaventura M and Biswas P and Feeney C et al}},

 doi = {{10.1007/s40257-023-00785-5}},

 volume = {{24}},

 journal = {{American Journal of Clinical Dermatology}},

 pages = {{609-621}},

 note = {{Accessed on 2024/12/22}}}